SCHEMBL5315852

SCHEMBL5315852

N#Cc1ccc(CN2CC3CN(CC(=O)NCCOc4ccc(C#N)cc4)CC(C2)O3)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRKAA2 P54646 1/20 0.47
KCNA5 P22460 4/20 0.45
KCNH2 Q12809 2/20 0.45
MMP3 P08254 1/20 0.45
DPP4 P27487 1/20 0.42
DPP8 Q6V1X1 1/20 0.42
CXCR3 P49682 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41
HSD17B10 Q99714 1/20 0.41
S1PR1 P21453 7/20 0.40
S1PR5 Q9H228 6/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
LMNA P02545 1/20 0.40
PKM P14618 1/20 0.40
S1PR3 Q99500 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5317598 0.95 KCNA5 (0.50) PRKAA2KCNA5KCNH2MMP3CXCR3
SCHEMBL5343106 0.90 KCNH2 (0.48) PRKAA2KCNA5KCNH2MMP3ALDH1A1
SCHEMBL5316242 0.85 ABCB1 (0.49) KCNA5KCNH2MMP3LMNAPKM
SCHEMBL5318090 0.85 KCNH2 (0.52) KCNA5KCNH2LMNAPKM
SCHEMBL5314851 0.85 POLB (0.53) PRKAA2DPP4DPP8ALDH1A1CYP3A4
SCHEMBL5317202 0.84 KCNH2 (0.60) PRKAA2KCNA5KCNH2MMP3
SCHEMBL5315943 0.82 KCNH2 (0.51) PRKAA2KCNA5KCNH2ALDH1A1POLB
SCHEMBL5317191 0.82 POLB (0.44) KCNA5KCNH2DPP4DPP8ALDH1A1
SCHEMBL5318355 0.81 POLB (0.60) DPP4DPP8ALDH1A1POLBMAPT
SCHEMBL5315856 0.81 POLB (0.49) ALDH1A1HSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007069986-A1 NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS ASTRAZENECA AB (SE) 2007-06-21 WO disclosed